Paloma Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,675
Closed -$596K 1391
2022
Q1
$596K Buy
+2,675
New +$599K 0.02% 660
2021
Q3
Sell
-1,553
Closed -$320K 1463
2021
Q2
$320K Sell
1,553
-745
-32% -$153K 0.01% 1268
2021
Q1
$472K Buy
+2,298
New +$485K 0.01% 1168
2020
Q4
Sell
-3,861
Closed -$706K 1905
2020
Q3
$706K Buy
3,861
+495
+15% +$93.2K 0.02% 943
2020
Q2
$620K Buy
+3,366
New +$669K 0.01% 1130
2019
Q4
Sell
-1,606
Closed -$257K 2319
2019
Q3
$257K Buy
+1,606
New +$320K 0.01% 1625
2018
Q3
Sell
-48,099
Closed -$14.1M 1716
2018
Q2
$14.1M Buy
48,099
+45,588
+1,816% +$12.5M 0.26% 62
2018
Q1
$634K Buy
+2,511
New +$590K 0.01% 1239
2017
Q2
Sell
-1,984
Closed -$303K 2299
2017
Q1
$303K Buy
+1,984
New +$290K ﹤0.01% 1738
2015
Q4
Sell
-3,033
Closed -$333K 1805
2015
Q3
$333K Sell
3,033
-1,941
-39% -$208K 0.01% 1235
2015
Q2
$476K Buy
+4,974
New +$465K 0.01% 1117

Other funds holding ICUI

Paloma Partners's ICUI Position: Q2 2022 in Review

Paloma Partners sold out of ICU Medical (ICUI) in Q2 2022, closing a stake of 2,675 shares — an estimated $596K sold.

Paloma Partners first reported a position in ICUI in Q2 2015 and held it in 11 quarters. The position peaked at $14.1M in Q2 2018. 258 funds tracked by Wall St. Rank hold ICUI as of Q2 2022.

  • Paloma Partners reported no remaining ICU Medical position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 2,675 ICU Medical shares in Q2 2022, an estimated $596K.
  • Paloma Partners first reported a position in ICU Medical in Q2 2015 and held it in 11 quarters.
  • Paloma Partners's ICU Medical position peaked at $14.1M in Q2 2018.
  • 258 funds tracked by Wall St. Rank held ICU Medical as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.